In vivo transdermal delivery of leuprolide using microneedles and iontophoresis

Current Pharmaceutical Biotechnology

Volumn 14, Issue 2, 2013, Pages 180-193

  Sachdeva, Vishal ^a   Zhou, Yingcong ^a   Banga, Ajay K ^a  

^a MERCER UNIVERSITY   (United States)

Author keywords

Drug delivery; Iontophoresis; Leuprolide acetate; Microneedles; Peptide; Transdermal

Indexed keywords

CALCEIN; LEUPRORELIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; ELECTRODE; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; IN VIVO STUDY; IONTOPHORESIS; MALE; MICRONEEDLE; MICROSCOPY; NONHUMAN; PERMEABILITY; RAT; SKIN WATER LOSS; STRATUM CORNEUM;

EID: 84875309122     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/1389201011314020008     Document Type: Article

References (37)

1. Wilson, A.C.; Meethal, S.V.; Bowen, R.L.; Atwood, C.S. Leuprolide acetate: a drug of diverse clinical applications. Expert. Opin. Investig. Drugs, 2007, 16, 1851-1863.
2. Magon, N. Gonadotropin releasing hormone agonists: Expanding vistas. Indian J. Endocrinol. Metab., 2011, 15, 261-267.
3. LexiCompOnline, http://online.lexi.com.proxy.mercer.edu/crlsql/servlet/crlonline (Leuprolide acetate accessed on January 19th, 2012).
4. Sachdeva, V.; Banga, A.K. Microneedles and their applications. Recent Pat. Drug Deliv. Formul., 2011, 5, 95-132.
5. Iqbal, J.; Shahnaz, G.; Perera, G.; Hintzen, F.; Sarti, F.; Bernkop-Schnurch, A. Thiolated chitosan: Development and in vivo evaluation of an oral delivery system for leuprolide. Eur. J. Pharm. Biopharm., 2012, 80, 95-102.
6. Ito, Y.; Murano, H.; Hamasaki, N.; Fukushima, K.; Takada, K. Incidence of low bioavailability of leuprolide acetate after percutaneous administration to rats by dissolving microneedles. Int. J. Pharm., 2011, 407, 126-131.
7. Karande, P.; Jain, A.; Mitragotri, S. Discovery of transdermal penetration enhancers by high-throughput screening. Nat. Biotechnol., 2004, 22, 192-197.
8. Kochhar, C.; Imanidis, G. In vitro transdermal iontophoretic delivery of leuprolide-mechanisms under constant voltage application. J. Pharm. Sci., 2003, 92, 84-96.
9. Kochhar, C.; Imanidis, G. In vitro transdermal iontophoretic delivery of leuprolide under constant current application. J. Control. Release, 2004, 98, 25-35.
10. Rastogi, S.K.; Singh, J. Lipid extraction and iontophoretic transport of leuprolide acetate through porcine epidermis. Int. J. Pharm., 2001, 215, 241-249.
11. Rastogi, S.K.; Singh, J. Iontophoretic enhancement of leuprolide acetate by fatty acids, limonene, and depilatory lotions through porcine epidermis. Pharm. Dev. Technol., 2004, 9, 341-348.
12. Sachdeva, V.; Banga, A.K. Skin Deep. Pharmaceutical Manufacturing and Packing Sourcer, 2009, p. 17-24.
13. Sachdeva, V.; Banga, A.K. Iontophoresis: Promises and Challenges. Transdermal, 2010; p. 17-21.
14. Banga, A.K. Transdermal and intradermal delivery of therapeutic agents: Application of physical technologies.: Taylor and Francis: London, 2011; pp.1-330.
15. Guy, R.H.; Kalia, Y.N.; Delgado-Charro, M.B.; Merino, V.; Lopez, A.; Marro, D. Iontophoresis: electrorepulsion and electroosmosis. J. Control. Release, 2000, 64, 129-132.
16. Hirvonen, J.; Kalia, Y.N.; Guy, R.H. Transdermal delivery of peptides by iontophoresis. Nat. Biotechnol., 1996, 14, 1710-1713.
17. Banga, A.K. Microporation applications for enhancing drug delivery. Expert. Opin. Drug Deliv., 2009, 6, 343-354.
18. Banga, A.K. Microneedle-Mediated Transdermal Delivery: How to Contribute to Meaningful Research to Advance this Growing Field. TransDermal, 2009; p. 8-13.
19. Prausnitz, M.R. Microneedles for transdermal drug delivery. Adv. Drug. Deliv. Rev., 2004, 56, 581-587.
20. Miyano, T.; Tobinaga, Y.; Kanno, T.; Matsuzaki, Y.; Takeda, H.; Wakui, M.; Hanada, K. Sugar micro needles as transdermic drug delivery system. Biomed. Microdevices, 2005, 7, 185-188.
21. Katikaneni, S.; Badkar, A.; Nema, S.; Banga, A.K. Molecular charge mediated transport of a 13 kD protein across microporated skin. Int. J. Pharm., 2009, 378, 93-100.
22. Katikaneni, S.; Li, G.; Badkar, A.; Banga, A. Transdermal delivery of a approximately 13 kDa protein--an in vivo comparison of physical enhancement methods. J. Drug. Target., 2010, 18, 141-147.
23. Lanke, S.S.; Kolli, C.S.; Strom, J.G.; Banga, A.K. Enhanced transdermal delivery of low molecular weight heparin by barrier perturbation. Int. J. Pharm., 2009, 365, 26-33.
24. Vemulapalli, V.; Yang, Y.; Friden, P.M.; Banga, A.K. Synergistic effect of iontophoresis and soluble microneedles for transdermal delivery of methotrexate. J. Pharm. Pharmacol., 2008, 60, 27-33.
25. Wu, X.M.; Todo, H.; Sugibayashi, K. Enhancement of skin permeation of high molecular compounds by a combination of microneedle pretreatment and iontophoresis. J. Control. Release., 2007, 118, 189-195.
26. Kalluri, H.; Banga, A.K. Formation and closure of microchannels in skin following microporation. Pharm. Res., 2010, 28, 82-94.
27. Li, G.; Badkar, A.; Kalluri, H.; Banga, A.K. Microchannels created by sugar and metal microneedles: characterization by microscopy, macromolecular flux and other techniques. J. Pharm. Sci., 2009, 99, 1931-1941.
28. Kolli, C.S.; Banga, A.K. Characterization of solid maltose microneedles and their use for transdermal delivery. Pharm. Res., 2008, 25, 104-113.
29. Okada, H.; Inoue, Y.; Heya, T.; Ueno, H.; Ogawa, Y.; Toguchi, H. Pharmacokinetics of once-a-month injectable microspheres of leuprolide acetate. Pharm. Res., 1991, 8, 787-791.
30. Gratieri, T.; Kalaria, D.; Kalia, Y.N. Non-invasive iontophoretic delivery of peptides and proteins across the skin. Expert Opin. Drug Deliv., 2011, 8, 645-663.
31. Coulman, S.; Allender, C.; Birchall, J. Microneedles and other physical methods for overcoming the stratum corneum barrier for cutaneous gene therapy. Crit. Rev. Ther. Drug Carrier Syst., 2006, 23, 205-258.
32. Gill, H.S.; Denson, D.D.; Burris, B.A.; Prausnitz, M.R. Effect of microneedle design on pain in human volunteers. Clin. J. Pain., 2008, 24, 585-594.
33. Sachdeva, V.; Kim, H.D.; Friden, P.M.; Banga, A.K. Iontophoresis mediated in vivo intradermal delivery of terbinafine hydrochloride. Int. J. Pharm., 2010, 393, 112-118.
34. Murahata, R.I.; Crowe, D.M.; Roheim, J.R. The use of transepidermal water loss to measure and predict the irritation response to surfactants. Int. J. Cosmet. Sci., 1986, 8, 225-231.
35. Chen, H.; Zhu, H.; Zheng, J.; Mou, D.; Wan, J.; Zhang, J.; Shi, T.; Zhao, Y.; Xu, H.; Yang, X. Iontophoresis-driven penetration of nanovesicles through microneedle-induced skin microchannels for enhancing transdermal delivery of insulin. J. Control. Release, 2009, 139, 63-72.
36. Kolli, C.S.; Xiao, J.; Parsons, D.L.; Babu, R.J. Microneedle assisted iontophoretic transdermal delivery of prochlorperazine edisylate. Drug Dev. Ind. Pharm., 2011, 571-576.
37. Lin, W.; Cormier, M.; Samiee, A.; Griffin, A.; Johnson, B.; Teng, C.L.; Hardee, G.E.; Daddona, P.E. Transdermal delivery of antisense oligonucleotides with microprojection patch (Macroflux) technology. Pharm. Res., 2001, 18, 1789-1793.